National Cancer Institute speakers

21 speakers from National Cancer Institute at B2B trade shows and conferences.

Dinah S. Singer

Deputy Director for Scientific Strategy and Development · National Cancer Institute

3 events
Cancer Moonshotcancer research strategyoncology innovation

Louis M. Staudt

National Cancer Institute

3 events
drug repurposingBruton Tyrosine Kinasesevere COVID-19

Shahrooz Vahedi

NCI-Center to Reduce Cancer Health Disparities

3 events
summary statementsgrant feedback

Douglas R. Lowy

National Cancer Institute

3 events
diagnostics developmentcancer researchvirology

Tiffany A. Wallace

NCI-Center to Reduce Cancer Health Disparities

3 events
grant writingNIH fundingresearch grants

Norman E. Sharpless

Director · National Cancer Institute

3 events
cancer researchnational cancer instituteoncology policy

Michele Bloch

National Cancer Institute

3 events
tobacco policycancer prevention

Shamala Srinivas

National Cancer Institute, Division of Extramural Activities

3 events
grant reviewfunding

Yamini Dalal

Ph.D. (Biochemie) · National Cancer Institute

2 events
histone biologyepigenetics

Kedar Narayan

National Cancer Institute, NIH

2 events
FIB-SEMImage analysis

Michael L. Salgaller

Supervisor, Invention Development and Marketing Unit · National Institutes of Health (NIH) | National Cancer Institute (NCI) | Technology Transfer Center

1 event

Mehdi Benzaoui

National Cancer Institute

1 event
CAR T manufacturingCD19activation platform

Elad Sharon

Cancer Therapy Evaluation Program

1 event
off-target effects

W. Kimryn Rathmell, MD, PhD

Hugh Jackson Morgan Professor and Chair of Medicine, Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics · Vanderbilt University Medical Center

1 event
basic sciencehuman health advancements

Lokesh Agrawal

Program Director · National Cancer Institute

1 event
cancer researchbiomarkers

Nirali N. Shah

National Cancer Institute/NIH

1 event
immunotherapy failurerelapse

Nirali Shah, MD, MHSc

1 event
CAR T-cellshyperinflammationimmunotherapy

Nirali Shah, MD

National Cancer Institute

1 event
CAR T relapseB-ALLrelapse prevention

Ming Zhao

Program Director, SBIR Development Center · National Cancer Institute

1 event
Cancer researchInnovation

Douglas Stewart

Senior Investigator · National Cancer Institute

1 event

Anthony Letai

Harvard Medical School and Dana-Farber Cancer Institute

1 event
functional precision medicinecancer therapies